all report title image
  • Published In : Jul 2024
  • Code : CMI201
  • Pages : 197
  • Formats :
      Excel/PDF
  • Industry : Pharmaceutical

Global sterile injectables market growth is driven by rising incidence of chronic diseases along with growing geriatric population worldwide who are more susceptible to such diseases. Sterile injectables are used in therapeutic areas like oncology, autoimmune diseases, hematology, ophthalmology, anesthesia, and others. Moreover, rising demand for biologics and affordability of these drugs can drive the market growth. However, stringent regulatory norms associated with sterile injectables production can hamper the market growth during the forecast period.

Market Dynamics:

Global sterile injectables market growth is driven by growing incidence of cancer and other chronic diseases globally. Growing geriatric population prone to chronic medical conditions can also boost demand for sterile injectables. Moreover, rising popularity of biologics over conventional drugs due to superior efficacy can offer new market growth opportunities. However, high production costs associated with sterile injectables due to stringent quality control standards imposed by regulatory authorities can hamper the market growth. Product recalls owing to contamination issues during manufacturing can hamper the market growth. Ongoing R&D activities for developing effective biosimilars can offer market growth opportunities in the near future.

Key Features of the Study:

  • This report provides in-depth analysis of the global sterile injectables market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook and competitive strategies adopted by key players.
  • It profiles key players in the global sterile injectables market based on the following parameters – company highlights, products portfolio, key highlights, financial performance and strategies.
  • Key companies covered as a part of this study include Pfizer Inc., Baxter International Inc., Abbott Laboratories and GlaxoSmithKline plc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion and marketing tactics.
  • Global sterile injectables market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sterile injectables market

Detailed Segmentation-

  • By Molecule Type
    • Large Molecules
    • Small Molecule
  • By Drug Type
    • Monoclonal Antibodies
    • Cytokines
    • Insulin
    • Peptide Hormones
    • Blood Factors
    • Vaccines
    • Immunoglobulins
    • Peptide Antibiotics
    • Others
  • By Disease Indication
    • Cancer
    • Diabetes
    • Cardiovascular Disorders
    • Musculoskeletal Disorders
    • CNS disorders
    • Infectious Disorders
    • Others
  •  By Route of Administration
    • Intravenous (IV)
    • Intramuscular (IM)
    • Subcutaneous (SC)
    • Others
  •   By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region           
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Pfizer Inc.
    • Merck & Co., Inc.
    • Johnson & Johnson
    • Baxter International Inc.
    • Novartis AG
    • Sanofi S.A.
    • GlaxoSmithKline plc (GSK)
    • AstraZeneca PLC
    • Gilead Sciences, Inc.
    • Amgen Inc.
    • AbbVie Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Bayer AG
    • Fresenius SE & Co. KGaA (Fresenius Kabi)
    • Becton, Dickinson and Company (BD)
    • Hoffmann-La Roche Ltd
    • Eli Lilly and Company

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Molecule Type
      • Market Snapshot, By Drug Type
      • Market Snapshot, By Disease Indication
      • Market Snapshot, By Route of Administration
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Regulatory Scenario
    • Acquisitions and Partnerships Scenario
    • Funding and Investments
    • PEST Analysis
    • Porter’s Analysis
  4. Global Sterile Injectables Market - Impact of Coronavirus (COVID-19) Pandemic
    • Overall Impact
    • Government Initiatives
    • COVID-19 Impact on the Market
  5. Global Sterile Injectables Market, By Molecule Type, 2019 – 2031, (USD Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2019 – 2031
      • Segment Trends
    • Large Molecules
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Small Molecule
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
  6. Global Sterile Injectables Market, By Drug Type, 2019 – 2031, (USD Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2019 – 2031
      • Segment Trends
    • Monoclonal Antibodies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Cytokines
      • Mammography
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Insulin
      • Chest X-ray
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Peptide Hormones
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Blood Factors
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Vaccines
      • Mammography
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Immunoglobulins
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Peptide Antibiotics
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
  7. Global Sterile Injectables Market, By Disease Indication, 2019 – 2031, (USD Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2019 – 2031
      • Segment Trends
    • Cancer
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Diabetes
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Cardiovascular Disorders
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Musculoskeletal Disorders
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • CNS disorders
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Infectious Disorders
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
  8. Global Sterile Injectables Market, By Route of Administration, 2019 – 2031, (USD Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2019 – 2031
      • Segment Trends
    • Intravenous
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Intramuscular
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Subcutaneous
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Others 
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
  9. Global Sterile Injectables Market, By Distribution Channel, 2019 – 2031, (USD Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2019 – 2031
      • Segment Trends
    • Hospital Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Retail Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Online Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
  10. Global Sterile Injectables Market, By Region, 2019 – 2031, (USD Bn)
    • Introduction
      • Market Share Analysis, By Region, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, For Region, 2019–2031
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2019 – 2031, (USD Bn)
        • North Africa
        • Central Africa
        • South Africa
  11. Competitive Landscape
    • Company Profiles
      • Pfizer Inc.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Merck & Co., Inc.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Johnson & Johnson
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Baxter International Inc.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Novartis AG
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Sanofi S.A.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • GlaxoSmithKline plc (GSK)
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • AstraZeneca PLC
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Gilead Sciences, Inc.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Amgen Inc.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • AbbVie Inc.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Teva Pharmaceutical Industries Ltd.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Bayer AG
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Fresenius SE & Co. KGaA (Fresenius Kabi)
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Becton, Dickinson and Company (BD)
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • F. Hoffmann-La Roche Ltd
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Eli Lilly and Company
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
  12. Analyst Recommendations
    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  13. References and Research Methodology
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 32 market data tables and 28 figures on "Sterile Injectables Market” - Global forecast to 2031

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.